Novel Hot Spot Mutations in BCR-ABL1: a Personalised Medicine Approach in Chronic Myeloid Leukaemia


IntroductionAcquisition of mutations in the BCR-ABL1 kinase domain (KD) is frequently associated with tyrosine kinase inhibitor (TKI) failure in chronic myeloid leukemia (CML). Recently, we revealed a novel mutation... [ view full abstract ]


  1. Erik Laurini (University of Trieste)
  2. Suzana Aulic (University of Trieste)
  3. Domenico Marson (University of Trieste)
  4. Maurizio Fermeglia (University of Trieste)
  5. Sabrina Pricl (University of Trieste)

Topic Area

Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et


PS1 » Poster Session (14:00 - Monday, 25th June, Main hall)

Presentation Files

The presenter has not uploaded any presentation files.